Amending Pharmaceutical Industry Practices Can Build Trust, Panellists Say 26/05/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment At a side event to this week’s World Health Assembly, GlaxoSmithKline detailed measures taken by the company to dispel the perception of conflict of interest, and build trust, including amending the ways its sales forces operate, and no longer paying speakers at scientific congresses, and said it wants to provide leadership on the issue. Patients and physicians associations call for mainstreaming those practices.
WHO Engagement With Outside Actors: Delegates Tight-Lipped, Civil Society Worried 24/05/2016 by Catherine Saez, Intellectual Property Watch 2 Comments This week, country delegates meeting at the annual World Health Assembly are expected to come to an agreement on a framework managing the UN World Health Organization’s relationship with outside actors, such as the private sector, philanthropic organisations and civil society groups.
Health Systems, Collaboration, Research Funding Before Innovation, Speakers Say 23/05/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The fight against epidemics cannot only rely on innovation, according to speakers at an event organised by the pharmaceutical industry alongside the annual World Health Assembly’s opening day. Strong health systems, collaboration of all stakeholders, preventive measures, and the ability to fund research are prerequisite to innovation, they said.
Washington Post- Colombia Battles World’s Biggest Drugmaker Over Cancer Drug 19/05/2016 by Intellectual Property Watch Leave a Comment [From the Washington Post] BOGOTA, Colombia — Colombia’s government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.
Amid Global Push For Tobacco Plain Packaging, IP And Health Rights Bog Down Africa 19/05/2016 by Munyaradzi Makoni for Intellectual Property Watch 3 Comments CAPE TOWN, South Africa — Plain packaging is considered unattractive among marketers, loss-making for industries, and a healthy life promoter for governments and the public. The potent mix to balance profits, safeguard jobs and cut illnesses has made it a controversial solution to curb smoking. As it grows in popularity around the world, how is plain packaging faring in Africa?
Public Health Advocates Urge WHO Action On Alternative R&D Financing 12/05/2016 by William New, Intellectual Property Watch 2 Comments Public health advocates last week told World Health Organization delegates they must act quickly to save the lives of poor populations suffering from less common diseases for which there is no research and development funding. Nongovernmental organisations showed up to a WHO meeting on the issue to urge on delegates, even holding a public demonstration in front of the UN, but there was concern afterward at the little progress made.
At WIPO, Music Industry Points Fingers At YouTube For Hiding Behind Safe Harbour 11/05/2016 by Catherine Saez, Intellectual Property Watch 1 Comment YouTube is recognised by many as the world’s biggest music platform. Listening to music on YouTube is free for users. However, according to the music industry, it pays very little in terms of revenue, mostly from advertising. It is time that the safe harbour laws behind which YouTube is hiding, creating a market distortion, be revised or better applied, music industry speakers asserted this week at a World Intellectual Property Organization side event.
Over 70 Groups Urge EU Telecom Regulators To Uphold Net Neutrality 05/05/2016 by Intellectual Property Watch Leave a Comment Dozens of civil society organisations this week sent a letter urging European telecommunications regulators to preserve internet neutrality in their current negotiations about the future of the internet in Europe.
MSF Issues In-Depth Report On R&D And Drug Prices 02/05/2016 by Intellectual Property Watch 3 Comments Médecins Sans Frontières (MSF, Doctor Without Borders) today announced a report detailing what it calls failings in the current system for developing new drugs in ways that all patients can afford and access, and providing proposed policy options for addressing the problems.
Discussions Continue On How To Govern WHO Interactions With Outside Actors 29/04/2016 by Catherine Saez, Intellectual Property Watch 3 Comments The World Health Organization interacts with a large number of actors aside from governments, such as industry, philanthropic organisations, academia, and civil society. With an eye to preventing undue influence on the work of the organisation, member states have been trying to finalise a draft framework on WHO interaction with those actors. This week, what was seen as a last effort at reaching a consensual text did not quite meet the goal and some additional informal discussions are expected to take place before the annual World Health Assembly in late May.